Related Experiment Video
Updated: Sep 26, 2025

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
Published on: September 15, 2021
U2AF1 mutation connects DNA damage to the alternative splicing of RAD51 in lung adenocarcinomas
Chuanhui Chen1, Pinglang Zhou1, Zhizhe Zhang1
1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Abstract:
The recurrent mutation (S34F) in splicing factor U2AF1 is frequently observed in lung adenocarcinoma, but its function remains largely unknown. To determine the mechanistic basis and consequences of U2AF1 mutations, we established non-small cell lung carcinoma A549 cell lines with exogenous expression of wildtype (U2AF1-WT) or mutant (U2AF1-S34F). Splicing analysis revealed that U2AF1-S34F mainly caused aberrant exon usage and affected splicing of numerous DNA damage repair genes. Compared to A549 cells expressing U2AF1-WT, cells expressing U2AF1-S34F showed enhanced DNA damage and cell death in response to ATR inhibitors (ATRi). Mechanistically, U2AF1-S34F induced mis-splicing and downregulation of a key homologous recombination protein RAD51. Overexpression of RAD51 could largely rescue the defective DNA damage response in cells expressing U2AF1-S34F. Moreover, A549 cells expressing U2AF1-S34F, but not U2AF1-WT, were highly sensitive to treatment even with low dose of RAD51 inhibitor on ATRi-induced DNA damage. Our results suggest that U2AF1-S34F causes mis-splicing of DNA damage repair factors in lung cancer and sensitizes cells to RAD51 inhibition.
Insights
The U2AF1-S34F mutation in lung cancer disrupts DNA repair factor splicing, increasing DNA damage and cell death. This mutation sensitizes cancer cells to RAD51 inhibition, offering a potential therapeutic strategy.
Area of Science:
- Molecular Biology
- Cancer Genetics
- RNA Splicing
Background:
- The U2AF1 S34F mutation is common in lung adenocarcinoma.
- The functional impact of this mutation is poorly understood.
Purpose of the Study:
- To investigate the mechanistic basis and consequences of U2AF1 mutations in lung cancer.
- To determine how U2AF1-S34F affects DNA damage repair and drug sensitivity.
Main Methods:
- Established A549 cell lines expressing wildtype (U2AF1-WT) or mutant (U2AF1-S34F) U2AF1.
- Conducted splicing analysis to identify affected genes.
- Assessed DNA damage and cell death in response to ATR inhibitors (ATRi).
Main Results:
- U2AF1-S34F caused aberrant exon usage and affected splicing of DNA damage repair genes.
- Cells with U2AF1-S34F exhibited increased DNA damage and cell death upon ATRi treatment.
- U2AF1-S34F led to RAD51 mis-splicing and downregulation, which could be rescued by RAD51 overexpression.
- U2AF1-S34F expressing cells showed heightened sensitivity to RAD51 inhibition combined with ATRi.
Conclusions:
- U2AF1-S34F mutation induces mis-splicing of DNA damage repair factors in lung cancer.
- This mis-splicing sensitizes lung cancer cells to RAD51 inhibition, particularly in the context of ATR inhibitor treatment.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
RNA Splicing
DNA Damage can Stall the Cell Cycle
Base Excision Repair
The first step of...

